Topics

Articles

How Well Can Biopharma Protect Itself Against Theft?

Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers

OPINION: Will Class-Wide REMS Programs Delay New Opioid Approvals?

Bill Gates: 'Vaccines Are A Miracle'

More and more parts of the healthcare industry are connecting

Coming Together

The emergence of specialty pharmacies, with fundamental differences from other types of pharmacy providers, warrants the establishment of manufacturer relationships

Specialty Pharmacy Providers Deserve Their Own Class of Trade

Drug companies should keep a goal of effective communications as the priority in medical publications

Transparency Is the Solution to the Medical-Journal 'Ghostwriting' Controversy

FDA struggles with the new world of social media

Can Fair Balance Exist on the Web?

New technologies are creating a powerful link between patients and healthcare providers. This Connected Health World has implications for pharmaceutical business practices

The Pharma Industry's Place in a Connected Health World

Aggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’

The Evolving Retail Pharmacy Channel: Implications for Manufacturers

The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one

Opinion